The associate professor of clinical neurology at Keck Medicine of USC discussed advancements in therapeutics, the growing focus on biomarkers, and ongoing challenges in myasthenia gravis. [WATCH TIME: 4 minutes]
Leila Darki, MD
Advertisement
Associate professor of clinical neurology at Keck Medicine of University of South Carolina.
Articles by Leila Darki, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Preliminary Phase 2 Data Support Therapeutic Development of Synaptic Regenerative Drug SPG302 in ALS
2
FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole
3
Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows
4
Therapeutic Promise and Mechanism of DYNE-101 to Treat Myotonic Dystrophy: Doug Kerr, MD, PhD
5
